Atrial Fibrillation and Heart Failure.
Leonard BergauPhilipp BengelVanessa SciaccaThomas FinkChristian SohnsPhilipp SommerPublished in: Journal of clinical medicine (2022)
Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and has a strong association with heart failure (HF). It often remains unclear if HF is the cause or consequence of AF due to the complexity of the processes that are involved in both the perpetuation of AF and the development of HF. To date, two therapeutic strategies are accepted as the standard of care in AF patients with heart failure. Rhythm control aims to permanently restore sinus rhythm, whereas a rate-control strategy aims to slow ventricular rate without the termination of AF. In the last 5 years a tremendous number of important studies have been published investigating the optimal therapeutic strategy in HF patients. This review highlights the important studies with respect to the involvement of AF in promoting left-ventricular dysfunction and discusses the optimal strategy in HF patients suffering from AF.
Keyphrases
- atrial fibrillation
- heart failure
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- left ventricular
- acute heart failure
- direct oral anticoagulants
- end stage renal disease
- ejection fraction
- newly diagnosed
- percutaneous coronary intervention
- healthcare
- randomized controlled trial
- peritoneal dialysis
- acute coronary syndrome
- coronary artery disease
- oxidative stress
- aortic stenosis
- quality improvement
- prognostic factors
- mitral valve